Events

Our senior expert speakers have been drawn from the life science industry, UK and EU regulatory authorities, the Department of Health and Social Care, NHS England, the National Institute for Health and Care Excellence (NICE), academia, research charities, and patient organisations. Taking place at 30 Euston Square on Tuesday 17th September, our speakers will discuss:...

Change is happening right across the procurement landscape with the NHS Supply Chain new operating model now fully operational. This ABHI conference will inform industry of the recent commercial developments...

HUB SPARKS is an event series aimed at bringing together academia, third sector, industry and health and social care working in the area of healthy ageing to understand the issues...

Legal Manufacturers of In Vitro Diagnostic products need to be aware of the scope and implications of the new European In Vitro Diagnostics Regulations 2017/746.  Organisations must be realistic and  prepared. Not only for the impact of changes in the short-term, but for the long-term implications to the development and maintenance of diagnostic products in...

While most of the molecular studies focus over mutational analysis, epigenetics-is the only science which is gaining momentum with its cheaper and faster technology, by making its way to the clinic. Moving on the path of clinical epigenetics, our 4th Annual MarketsandMarkets Epigenetics Congress will discuss the solutions to challenges like, drug discovery, identification of...

This breakfast event in partnership with AdamsonJones will provide an invaluable opportunity to identify IP Considerations at the right stage of the R&D/NPD Process. Topics will include: Synchronising IP Considerations with your R&D/NPD Process -Typical stages in the NPD process/research process -IP protection opportunities and threats for each stage -Benefits for the end product design...

The Welsh Cancer Network, on behalf of the Cancer Implementation Group in Wales is convening industry colleagues to share a briefing on the landscape of the current challenges, strategic direction, research, interventions and opportunities for collaborative innovation. The group, with the Welsh Cancer Research Centre and Life Sciences Hub Wales have come together to deliver...